Early combination therapy with a thiazolidinedione for the treatment of type 2 diabetes

scientific article published on November 2003

Early combination therapy with a thiazolidinedione for the treatment of type 2 diabetes is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1177/014572170302900605
P698PubMed publication ID14692369

P2093author name stringGinger Kanzer-Lewis
P2860cites workAssociation of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational studyQ24652963
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001Q29614193
A systematic review of the associations between dose regimens and medication complianceQ30719289
Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study GroupQ31976463
Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.Q33864120
Pathophysiology of insulin resistance in human disease.Q40453488
Glycemic control and heart failure among adult patients with diabetesQ43628822
Efficacy and safety of rosiglitazone plus metformin in Mexicans with type 2 diabetesQ43982800
Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes.Q44016357
Racial and ethnic differences in glycemic control of adults with type 2 diabetesQ46478908
Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.Q51551544
Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents.Q51613168
Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state.Q54060454
P433issue6
P921main subjecttype 2 diabetesQ3025883
P304page(s)954-8, 961
P577publication date2003-11-01
P1433published inThe Science of Diabetes Self-Management and CareQ7730051
P1476titleEarly combination therapy with a thiazolidinedione for the treatment of type 2 diabetes
P478volume29

Reverse relations

Q39370163Establishment of a cell-based drug screening model for identifying agonists of human peroxisome proliferator-activated receptor gamma (PPARγ).cites workP2860

Search more.